share_log

新興市場銘柄ダイジェスト:リグアは大幅に反落、PRISMBioがストップ高

Emerging Market Stock Digest: Rigua fell sharply, while PRISM Bio hit the limit up.

Fisco Japan ·  Jul 3 14:25

<7090> Rigua 1980 -410. Fell significantly. Although it briefly hit the daily limit in the morning, it turned negative compared to the previous day due to profit-taking. Rigua announced that its new product "SLEEPINSTANT," a functional mineral crystal for aggregation that the company develops, was introduced into all rooms (784 beds in total) of the Kansai Airport Washington Hotel (Izumisano City, Osaka Prefecture) on the previous day, and investment funds flowed in. By placing the IFMC. close to the body, blood flow promotion effect can be expected due to vasodilation.

It fell sharply. Although it temporarily hit the daily limit in the morning, it has turned negative compared to the previous day due to profit-taking selling pressure. Rigua announced that its new product "SLEEPINSTANT", a functional mineral crystal (IFMC.) product developed by the company, has been introduced into all rooms (784 beds) at the Kansai Airport Washington Hotel (Izumisano City, Osaka Prefecture), which caused an influx of investment funds. IFMC is expected to promote blood circulation by dilating blood vessels when it comes into close contact with the body.

Use your Futubull account to access.

Significantly continued to rise. Tokai Tokyo Intelligence Lab has initiated new coverage with a rating of 'outperform' and a target stock price of 6200 yen (previous day's closing price was 3270 yen). They evaluated it as 'expecting to monetize generated AI-equipped products', and expects an operating profit estimate of 1.764 billion yen (company plan is 1.7 billion yen) for the fiscal year ending March 2025, 2.786 billion yen for the fiscal year ending March 2026, and 3.841 billion yen for the fiscal year ending March 2027.

<206A> PRISMBio 669 +100

The stock has hit its daily upper limit with buying momentum still strong, even after opening at a first price of 489 yen, surpassing the offering price of 450 yen, and being listed for the first time. The company is engaged in drug discovery, and has licensing contracts for its in-house development projects with Eisai <4523> and Ohara Pharmaceutical Industries in Tokyo's Chuo Ward, as well as partnerships with Ono Pharmaceutical Industry <4528> and others in joint development projects. Despite an expected operating loss of 888 million yen for the fiscal year ending September 2024 (compared to an actual loss of 496 million yen in the previous year), revenue is expected to expand to 300 million yen, an increase of 267.8% from the previous year.

<5027> AnyMind 1166 +75

Markedly rising. It has disclosed the main questions and their answers received from investors in the second quarter of fiscal year 24. In it, it mentioned that there is a possibility that the scale of M&A will gradually increase with the growth of the entire company, and stated that it wants to gradually increase the number of annual M&A cases, becoming a buying opportunity. In addition, it seems that it is being well received. Last year, it revealed that the gross profit of D2C/EC business, excluding contributions from the acquisition of DDI, increased by 65% year-on-year in the first quarter, which may have contributed to this.

<2983> R Planner 1036 +150. Daily limit rise

Daily limit rise. Revised upward the operating profit forecast for the year ending January 2025 from the previous 85 million yen to 1.18 billion yen (previous year's actual 53.2 billion yen). Sales gross profit has improved due to increased sales units of detached houses and appropriate pricing, as well as the decline in the prices of some building materials. At the same time, the year-end dividend forecast was revised upward from the previous 10.00 yen to 15.00 yen (actual results for the previous year-end 10.00 yen), and will be 30.00 yen (previous year 15.00 yen) annually.

<4268> Edge Technology 606 +28

Markedly high. It has revealed the public tender cases for orders or indications received in FY 24 through strengthening the digital human resource development of administrative organs and local governments through AI education services. As well as local governments such as Tokyo's ICT Occupational Training (Basic) and Shizuoka Prefecture's In-house Advanced AI Human Resource Development Course, it has also received orders from the Defense Equipment Agency for basic AI training. By incorporating unique proposals to solve issues faced by administrative organs and local governments through data utilization, it has led to orders.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment